ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Evaluation of Prexasertib, a Checkpoint Kinase 1 Inhibitor, in a Phase Ib Study of Patients with Squamous Cell Carcinoma.

David S Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.